Contact us

877-469-1TRM
424-208-8866

Previous Study | Return to List | Next Study Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine With or Without Birinapant With a Single Arm Open-Label Run-In Phase in Subjects With Higher Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
MDS OR CML Birinapant II Open and Accruing